These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38171911)

  • 1. Utility of Cytochrome P450 4F2 Genotyping to Assess Drug Interaction Risk for Brincidovovir, a Cytochrome P450 4F2 Substrate.
    Tippin T; Faison S; Schuck V; Dunn J; Naderer O
    Clin Pharmacol Drug Dev; 2024 Mar; 13(3):288-296. PubMed ID: 38171911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency of cytochrome 4F2 rs2108622 genetic variant and its effects on the lipid profile and complications of type II diabetes among a sample of patients in Jordan: A pilot study.
    Jarrar Y; Alkhalili M; Alhawari H; Abaalkhail SJ; Alkhalili S; Alhawari H; Momani M; Obeidat AN; Fram RK
    Prostaglandins Other Lipid Mediat; 2023 Apr; 165():106715. PubMed ID: 36758722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials.
    Athinarayanan S; Wei R; Zhang M; Bai S; Traber MG; Yates K; Cummings OW; Molleston J; Liu W; Chalasani N
    PLoS One; 2014; 9(4):e95366. PubMed ID: 24759732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation.
    Chan-Tack K; Harrington P; Bensman T; Choi SY; Donaldson E; O'Rear J; McMillan D; Myers L; Seaton M; Ghantous H; Cao Y; Valappil T; Birnkrant D; Struble K
    Antiviral Res; 2021 Nov; 195():105182. PubMed ID: 34582915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficacy of brincidofovir against variola virus.
    Olson VA; Smith SK; Foster S; Li Y; Lanier ER; Gates I; Trost LC; Damon IK
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5570-1. PubMed ID: 24957837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterization of 29 Cytochrome P450 4F2 Variants Identified in a Population of 8380 Japanese Subjects and Assessment of Arachidonic Acid
    Sato Y; Hishinuma E; Yamazaki S; Ueda A; Kumondai M; Saito S; Tadaka S; Kinoshita K; Nakayoshi T; Oda A; Maekawa M; Mano N; Hirasawa N; Hiratsuka M
    Drug Metab Dispos; 2023 Dec; 51(12):1561-1568. PubMed ID: 37775333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brincidofovir: A Novel Agent for the Treatment of Smallpox.
    Huston J; Curtis S; Egelund EF
    Ann Pharmacother; 2023 Oct; 57(10):1198-1206. PubMed ID: 36688308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox.
    Chittick G; Morrison M; Brundage T; Nichols WG
    Antiviral Res; 2017 Jul; 143():269-277. PubMed ID: 28093339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.
    Grossi IM; Foster SA; Gainey MR; Krile RT; Dunn JA; Brundage T; Khouri JM
    Antiviral Res; 2017 Jul; 143():278-286. PubMed ID: 28392420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.
    Bardowell SA; Stec DE; Parker RS
    J Nutr; 2010 Nov; 140(11):1901-6. PubMed ID: 20861217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.
    Foster SA; Parker S; Lanier R
    Viruses; 2017 Oct; 9(11):. PubMed ID: 29773767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CYP4F2 gene polymorphisms on warfarin clearance and sensitivity in Korean patients with mechanical cardiac valves.
    Lee KE; Chang BC; Kim HO; Yoon IK; Lee NR; Park HY; Gwak HS
    Ther Drug Monit; 2012 Jun; 34(3):275-82. PubMed ID: 22549502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11.
    Edson KZ; Prasad B; Unadkat JD; Suhara Y; Okano T; Guengerich FP; Rettie AE
    Biochemistry; 2013 Nov; 52(46):8276-85. PubMed ID: 24138531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox.
    Crump R; Korom M; Buller RM; Parker S
    Antiviral Res; 2017 Mar; 139():112-116. PubMed ID: 28039021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
    Parker S; Crump R; Foster S; Hartzler H; Hembrador E; Lanier ER; Painter G; Schriewer J; Trost LC; Buller RM
    Antiviral Res; 2014 Nov; 111():42-52. PubMed ID: 25128688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.
    Cheng J; Edin ML; Hoopes SL; Li H; Bradbury JA; Graves JP; DeGraff LM; Lih FB; Garcia V; Shaik JS; Tomer KB; Flake GP; Falck JR; Lee CR; Poloyac SM; Schwartzman ML; Zeldin DC
    FASEB J; 2014 Jul; 28(7):2915-31. PubMed ID: 24668751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis.
    Liang R; Wang C; Zhao H; Huang J; Hu D; Sun Y
    Thromb Res; 2012 Jul; 130(1):38-44. PubMed ID: 22192158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke.
    Munshi A; Sharma V; Kaul S; Al-Hazzani A; Alshatwi AA; Shafi G; Koppula R; Mallemoggala SB; Jyothy A
    Mol Biol Rep; 2012 Feb; 39(2):1677-82. PubMed ID: 21625857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Ketoconazole, a CYP4F2 Inhibitor, and CYP4F2*3 Genetic Polymorphism on Pharmacokinetics of Vitamin K
    Park JW; Kim KA; Park JY
    J Clin Pharmacol; 2019 Nov; 59(11):1453-1461. PubMed ID: 31134657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.